Literature DB >> 2480702

Kinetics of histamine released from rectal mucosa.

M Raithel1, A M Hörauf, M Matek, H W Baenkler.   

Abstract

This kinetic study was performed to investigate the different tissue-influencing histamine amounts in Crohn's Disease (CD), Ulcerative Colitis (UC), patients with polyps and cancers (P.a.C.Gr) and in a Control Group (CG). For this purpose the endoscopically obtained specimens from rectal mucosa were immediately placed into 1000 microliters of Hank's incubation medium in order to determine the spontaneously released histamine amounts at the time points of 5, 10, 15, 20 and 30 minutes. Each time a volume of 100 microliters was removed from the incubation medium and the kinetic value (KV) was detected by using the single isotope radioenzymatic method. Influencing of natural histamine catabolism and the comparison of the tissue histamine release with or without air oxygen in the incubation medium using four kinetic programmes (KP1-4) provides clearly different KVs, not only between the KPs but also within the same KP. The P.a.C.Gr. shows higher kinetic values (KVs) compared with the CG. In KP1-3 the kinetic courses (KCs) of the Inflammatory Bowel Diseases (IBDs), CD and UC-both not yet divided in active (a.) or not active (n.a.) disease stages-cross the KCs of the CG several times. Only the differentiation of the IBDs in active and not active disease stages in KP4 reveals that CDa. and UCa. stand out from the CG by higher KVs, and in contrast, CDn.a. and UCn.a. have lower KVs than the CG. The released amounts of histamine in CDa. and UCa. are significantly higher than in CDn.a. and UCn.a.

Entities:  

Mesh:

Year:  1989        PMID: 2480702     DOI: 10.1007/bf01967396

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  7 in total

1.  Mast cells and immunoglobulin E in inflammatory bowel disease.

Authors:  G Lloyd; F H Green; H Fox; V Mani; L A Turnberg
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

2.  Rectal IgE cells in inflammatory bowel disease.

Authors:  D P O'Donoghue; P Kumar
Journal:  Gut       Date:  1979-02       Impact factor: 23.059

3.  A rapid and sensitive enzymatic-isotopic method for routine assay of histamine in blood, plasma and biopsy tissue: re-evaluation.

Authors:  N Subramanian; P Mitznegg; W Domschke
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1978-12

4.  Intestinal monoamine oxidase: does it have a role in histamine catabolism?

Authors:  J Kusche; K D Feussner; W Lorenz
Journal:  Agents Actions       Date:  1982-04

5.  Kinetic analysis of the histamine N-methyltransferase reaction as used in the histamine radioenzymatic assay: optimization of assay specificity.

Authors:  K M Verburg; R R Bowsher; D P Henry
Journal:  Life Sci       Date:  1984-07-16       Impact factor: 5.037

6.  The start of a programme for measuring diamine oxidase activity in biopsy specimens of human renal mucosa.

Authors:  R Hesterberg; J Kusche; C D Stahlknecht; K D Feussner
Journal:  Agents Actions       Date:  1981-04

7.  Binding of histamine by glass surfaces.

Authors:  K M Verburg; D P Henry
Journal:  Agents Actions       Date:  1984-06
  7 in total
  4 in total

1.  Role of histamine in a rat model of colitis.

Authors:  C M Gelbmann; K E Barrett
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

2.  Decreased histamine catabolism in the colonic mucosa of patients with colonic adenoma.

Authors:  Michael A Kuefner; Hubert G Schwelberger; Eckhart G Hahn; Martin Raithel
Journal:  Dig Dis Sci       Date:  2007-06-12       Impact factor: 3.199

Review 3.  Diamine oxidase in relation to diamine and polyamine metabolism.

Authors:  A Sessa; A Perin
Journal:  Agents Actions       Date:  1994-11

4.  Relationship between mast cells and the colitis with relapse induced by trinitrobenzesulphonic acid in Wistar rats.

Authors:  Ana Carolina Luchini; Déborah Mara Costa de Oliveira; Cláudia Helena Pellizzon; Luiz Claudio Di Stasi; José Carlos Gomes
Journal:  Mediators Inflamm       Date:  2009-05-11       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.